Skip to main content

Aeterna Zentaris Inc(AEZS-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Aeterna Zentaris Inc flat on Tuesday (AEZS)

Automated Summaries - The Globe and Mail - Tue Apr 16, 4:02PM CDT

In market activity today, shares of Aeterna Zentaris Inc opened at $2.73 and closed at $2.70. Intraday prices ranged from $2.70 to $2.74.

Shares $verbed percentage_change% from the previous day's close of $2.70.

Today across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Aeterna Zentaris Inc has listed on the Toronto Stock Exchange (TSX) under the ticker AEZS.

A total of 3,000 shares was traded during the session, with total trades of 13. On average, Aeterna Zentaris Inc has traded 1,089 shares over the last 5-days and 1,954 year-to-date.

The TSX overall saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, AEZS.TO has traded as high as $4.48 (April 25,2023) and low as $1.91 (November 01,2023). Moreover, the shares have shrunken -23.73% in the last year, while they have boosted 5.06% year-to-date.

It announced a 1237.50 dividend on July 22/99, with an August 11/99 ex-date and January 01/70 pay day.

Following today's trading, Aeterna Zentaris Inc has a market capitalization of $13.11 million on a float of 4,856 shares outstanding. Its annual EPS is $-3.41.

Aeterna Zentaris Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Aeterna Zentaris Inc is holding an average recommendation of "Strong Buy" from 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe